Evidence map›Paper›PMID 40535733›Full record

ArticleTherapeutic advances in medical oncology2025

Proceedings of the seventh annual Women in Melanoma Conference.

Yana G Najjar, Marlana Orloff, Tara C Mitchell, Tawnya L Bowles, Allison Betof Warner, Kathryn Bollin, Sunandana Chandra, Justine V Cohen, Zeynep Eroglu, Pauline Funchain and 16 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in medical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Yana G NajjarUPMC Hillman Cancer Center, 5150 Center Ave, Pittsburgh, PA 15232-1309, USA.ORCID https://orcid.org/0000-0002-0138-1664
Marlana OrloffSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Tara C MitchellDepartment of Internal Medicine, Hematology/Oncology, Abramson Cancer Center, Philadelphia, PA, USA.
Tawnya L BowlesDepartment of Surgery, Intermountain Medical Center, Murray, UT, USA.
Allison Betof WarnerDivision of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA.
Kathryn BollinDepartment of Hematology and Oncology, Scripps Cancer Center, La Jolla, CA, USA.
Sunandana ChandraDivision of Hematology Oncology, Department of Medicine, Northwestern University, Chicago, IL, USA.
Justine V CohenDepartment of Medicine, Dana-Farber Cancer Institute Boston, Boston, MA, USA.
Zeynep ErogluDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Pauline FunchainDivision of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA.
Elizabeth GaughanDivision of Hematology and Medical Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Isabella Glitza OlivaDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Sherry HsuDepartment of Hematology and Oncology, Kaiser Permanente Riverside Medical Center, Riverside, CA, USA.
Siwen Hu-LieskovanDepartment of Medical Oncology, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Lucy Boyce KennedyDepartment of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
Thach-Giao TruongDepartment of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
Meredith McKeanDepartment of Medical Oncology, Sarah Cannon, Medical Oncology, Hematology, Nashville, TN, USA.
Janice MehnertDepartment of Medicine Melanoma and Cutaneous Medical Oncology, Perlmutter Cancer Center of NYU Langone Health, Manhattan, NY, USA.
Helen MoonDepartment of Hematology and Oncology, Kaiser Permanente Riverside Medical Center, Riverside, CA, USA.
Katy K TsaiDepartment of Medicine, UCSF, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Melissa WilsonDivision of Medical Oncology, St. Luke's University Health Network, Easton, PA, USA.
Thuy TranDepartment of Medical Oncology, Yale Cancer Center, New Haven, CT, USA.
Elizabeth I BuchbinderDepartment of Medicine, Dana-Farber Cancer Institute Boston, Boston, MA, USA.
Leslie A FecherDivision of Hematology/Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
Samantha GuildAIM at Melanoma, Richmond, CA, USA.
Sapna P PatelDepartment of Medical Oncology, University of Colorado, Denver, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

healthcare disparityimmunotherapymedical oncologymelanomasurvivorship < quality of life

Identifiers

PMID40535733
PMCPMC12174741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.